Press Releases Choose Year All Items 2025 2024 Search Press Releases Found 15 Results November 24, 2025 LB Pharmaceuticals Announces Presentation at the Piper Sandler 37th Annual Healthcare Conference November 12, 2025 LB Pharmaceuticals Appoints Kaya Pai Panandiker as Chief Commercial Officer November 12, 2025 LB Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4) November 6, 2025 LB Pharmaceuticals Reports 3Q 2025 Financial Results and Recent Corporate Updates November 6, 2025 LB Pharmaceuticals Announces Presentation at the Stifel 2025 Healthcare Conference October 14, 2025 LB Pharmaceuticals Appoints James Rawls, Pharm.D., as Senior Vice President of Regulatory Affairs October 6, 2025 LB Pharmaceuticals to Present Three Posters at 38th ECNP Congress Highlighting Clinical Activity and Safety Profile of LB-102 in Schizophrenia, Including Positive Effects on Cognition and Negative Symptoms September 25, 2025 LB Pharmaceuticals Strengthens Board of Directors with Appointments of William Kane and Rekha Hemrajani September 10, 2025 LB Pharmaceuticals Announces Pricing of its Upsized Initial Public Offering March 31, 2025 LB Pharmaceuticals Presents New Data from Phase 2 Clinical Trial of LB-102 at the 2025 Annual Congress of the Schizophrenia International Research Society 12»
